NOX1 and urothelial carcinoma: Several researches indicate that the decrease in NOX1 expression in urothelial carcinoma results in a decline in the generation of reactive oxygen species (ROS) and a resistance to programmed cell death, ultimately contributing to the progression of bladder cancer [29].